PwC’s narrower measure of traditional U.S. IPOs recorded 65 offerings raising approximately $114.2 billion through June, against 34 raising $14.8 billion in the first half of 2025
A landmark transaction supplied much of the proceeds, but issuance excluding it was still nearly three times the prior-year level.
Nearly half of the year’s IPOs priced at or above the top of their range, 97% opened above the offer price, and the average first-half IPO outperformed the S&P 500 by 8%.
The differing SEC and PwC totals illustrate a persistent nuisance: definitions matter. Some counts include SPACs, foreign issuers and closed-end funds; others do not. Both point the same direction.
The reopening is real. It is also concentrated in scale, liquidity and stories that can be underwritten without imaginative accounting.
Going public replaces periodic private negotiation with a continuous auction. A company valued privately once every 12 months may be repriced publicly many times in a single session. The public valuation is no less legitimate for being continuous.
Public investors will fund growth and tolerate losses that buy something measurable — capacity, share, recurring customers, proprietary technology, distribution advantage. They are less patient when adjusted metrics remove the ordinary costs of operating the company.
Adjusted EBITDA can explain the bridge. It cannot become the destination.
Those 264 first-quarter follow-ons raising $44.2 billion are the point. A public company can issue common equity, convertibles, an at-the-market program or stock as acquisition consideration; early investors and employees can obtain liquidity without the company selling new shares.
Issuing equity below intrinsic value can cost more than borrowing. Issuing debt to avoid dilution can cost more still if the business cannot service it. Public capital provides more instruments, not an exemption from arithmetic.
A company that raises only enough to complete the IPO has completed the transaction and missed the purpose.
PE-backed IPO value reached $27.6 billion across 12 listings in the second quarter — the only major sponsor exit channel to grow sequentially.
An IPO rarely lets a sponsor sell its whole position. Lockups, concentration and trading liquidity require installments. The company is public while its capital-allocation decisions may still be shaped by the fund’s distribution needs.
PitchBook counted a record 945 active U.S. unicorns at the end of the quarter, up 9.4% from year-end 2025, with aggregate post-money valuation of roughly $5.3 trillion.
That is a great deal of paper value waiting for a small door. The largest listings generate historic totals while distributing cash to a limited set of managers. The next test is not another record IPO; it is a sequence of reasonably priced offerings that trade well through earnings, lockup expirations and follow-on sales.
For companies financed at peak private valuations, accepting a lower IPO price may be the first step toward a healthier capital structure. Public markets do not owe a company its last preferred-round valuation.
The consumer IPO market showed real signs of life. Once Upon a Farm completed its February offering at $18 per share after reporting $225.9 million of net sales for the 12 months ended September 2025 and a 64.4% compound annual growth rate from 2018. Suja Life priced 8.9 million shares at $21 in May, in a roughly $624 million offering — one of only two food and beverage CPG public listings in the quarter, after none in the first.
These create visible comparables that will influence how venture investors, sponsors and strategic buyers value the rest of the category.
A private consumer company can explain a weak quarter as investment in distribution. A public one must explain whether the new distribution produced velocity, repeat purchase and contribution margin — and whether guidance follows shipments or underlying demand. Retailer orders move between quarters, and guidance built on shipments rather than consumption carries a miss the company may not see coming.
The reporting calendar is quarterly. Agriculture is seasonal, biological, cyclical and weather-exposed.
Agricultural issuers should separate land value from operating returns, commodity exposure from value-added processing margin, realized earnings from inventory and hedge movements, volume from price, maintenance capital from expansion capital, temporary utilization issues from structural constraints, contracted revenue from spot exposure, and biological risk from controllable execution.
A farm-rich balance sheet does not guarantee an attractive public valuation. Investors discount acreage embedded in an operating company when the land produces weak cash flow or serves mainly as collateral for growing debt.

SPAC issuance accelerated to 118 IPOs raising approximately $20.9 billion in the first half, against 66 raising $11.8 billion a year earlier. Only 18 de-SPAC transactions completed, down from 22.
Forming an acquisition vehicle is not the same as finding a company investors want to own. Redemptions, PIPE financing, dilution, sponsor incentives and post-combination trading remain part of the economics.
The SEC has meanwhile proposed material changes to the registered-offering framework: expanded shelf eligibility, broader incorporation by reference into Form S-1, extended scaled disclosures, a large-accelerated-filer threshold rising from $700 million to $2 billion, at least five years of IPO on-ramp accommodations, and an exemption for non-accelerated filers from auditor attestation on internal control. As of July 24 these were proposals, not final rules.